In last trading session, Medtronic plc (NYSE:MDT) saw 9.07 million shares changing hands with its beta currently measuring 0.72. Company’s recent per share price level of $81.77 trading at -$0.19 or -0.23% at ring of the bell on the day assigns it a market valuation of $108.76B. That closing price of MDT’s stock is at a discount of -12.54% from its 52-week high price of $92.02 and is indicating a premium of 7.35% from its 52-week low price of $75.76. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.17 million shares which gives us an average trading volume of 4.76 million if we extend that period to 3-months.
For Medtronic plc (MDT), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.50. Splitting up the data highlights that, out of 32 analysts covering the stock, 2 rated the stock as a Sell while 6 recommended an Overweight rating for the stock. 14 suggested the stock as a Hold whereas 10 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $1.18 in the current quarter.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
Medtronic plc (NYSE:MDT) trade information
Upright in the red during last session for losing -0.23%, in the last five days MDT remained trading in the green while hitting it’s week-highest on Friday, 09/15/23 when the stock touched $81.77 price level, adding 0.75% to its value on the day. Medtronic plc’s shares saw a change of 5.21% in year-to-date performance and have moved 2.26% in past 5-day. Medtronic plc (NYSE:MDT) showed a performance of 0.25% in past 30-days. Number of shares sold short was 6.83 million shares which calculate 1.4 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $92.92 to the stock, which implies a rise of 12.0% to its current value. Analysts have been projecting $80.00 as a low price target for the stock while placing it at a high target of $104.00. It follows that stock’s current price would drop -27.19% in reaching the projected high whereas dropping to the targeted low would mean a gain of 2.16% for stock’s current value.
Medtronic plc (MDT) estimates and forecasts
Statistics highlight that Medtronic plc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 3.15% of value to its shares in past 6 months, showing an annual growth rate of -3.21% while that of industry is 18.10. Apart from that, the company came lowering its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to decrease by -9.20% in the current quarter and calculating -3.80% decrease in the next quarter. This year revenue growth is estimated to rise 3.00% from the last financial year’s standing.
24 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $7.93 billion for the same. And 24 analysts are in estimates of company making revenue of $8.01 billion in the next quarter that will end on Jan 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -6.50% during past 5 years. In 2023, company’s earnings growth rate is likely to be around -24.40% while estimates for its earnings growth in next 5 years are of 3.47%.
MDT Dividends
Medtronic plc is more likely to be releasing its next quarterly report in October and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Medtronic plc (NYSE:MDT)’s Major holders
- Tags: MDT, MDT stock, Medtronic plc, NYSE:MDT
